209 related articles for article (PubMed ID: 10174475)
1. Pharmaceutical cost containment and innovation in the United States.
Kane NM
Health Policy; 1997 Sep; 41 Suppl():S71-89. PubMed ID: 10174475
[TBL] [Abstract][Full Text] [Related]
2. The management of the cost and utilisation of pharmaceuticals in the United Kingdom.
Burstall ML
Health Policy; 1997 Sep; 41 Suppl():S27-43. PubMed ID: 10174472
[TBL] [Abstract][Full Text] [Related]
3. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
4. The drug budget silo mentality: the French case.
Le Pen C
Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
[TBL] [Abstract][Full Text] [Related]
5. Controlling the cost of branded drugs.
Mandelker J
Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
MacEachern L
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
[TBL] [Abstract][Full Text] [Related]
7. Projecting future drug expenditures--1998.
Mehl B; Santell JP
Am J Health Syst Pharm; 1998 Jan; 55(2):127-36. PubMed ID: 9465976
[TBL] [Abstract][Full Text] [Related]
8. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
9. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
10. What Determines How Much Your Patient Pays for Their Medication in the United States?
Novack GD
Am J Ophthalmol; 2016 Jul; 167():48-51. PubMed ID: 27131775
[TBL] [Abstract][Full Text] [Related]
11. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
Mendoza RL
J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
[TBL] [Abstract][Full Text] [Related]
12. Cost and utilisation of pharmaceuticals in Sweden.
Ljungkvist MO; Andersson D; Gunnarsson B
Health Policy; 1997 Sep; 41 Suppl():S55-69. PubMed ID: 10174474
[TBL] [Abstract][Full Text] [Related]
13. Comparative experience in home care and pharmaceutical policy.
Kane NM; Saltman RB
Health Policy; 1997 Sep; 41 Suppl():S1-7. PubMed ID: 10174467
[No Abstract] [Full Text] [Related]
14. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
15. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
Huskamp HA; Epstein AM; Blumenthal D
Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
[TBL] [Abstract][Full Text] [Related]
16. Approaches to pharmacy benefit management and the impact of consumer cost sharing.
Olson BM
Clin Ther; 2003 Jan; 25(1):250-72. PubMed ID: 12637125
[TBL] [Abstract][Full Text] [Related]
17. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
18. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
19. Employers push to manage prescription drug costs.
Frieden J
Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
[No Abstract] [Full Text] [Related]
20. Precipitating factors for pharmaceutical firms.
McCarthy R
State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
